The invention discloses a traditional Chinese medicinal composition for treating blood group incompatibility haemolytic
disease, and belongs to the field of traditional Chinese medicines. Regarding the existing technical defects of high hepatotoxicity and poor
curative effect of a current
chemical treatment medicament for treating blood group incompatibility haemolytic
disease, the invention provides the traditional Chinese medicinal composition for treating or preventing blood group incompatibility haemolytic
disease, which comprises the following raw materials in parts by weight: 10 to 50 parts of burdock, 10 to 20 parts of oriental wormwood, 5 to 20 parts of Chinese angelica, 5 to 15 parts of common yam
rhizome, 5 to 10 parts of cape jasmine, 5 to 15 parts poria, 5 to 15 parts of radix pseudostellariae, 1 to 10 parts of
ginseng, 5 to 15 parts of medlar, 9 to 15 parts of
astragalus, 9 to 15 parts of golden thread, 5 to 15 parts of rhizoma alismatis, 1.5 to 9 parts of
radix ophiopogonis, 5.5 to 15 parts of white peony root, 6 to 9 parts of
motherwort, and 10 to 15 parts of liquorice. The traditional Chinese medicinal composition has a good
treatment effect in the field of treating or preventing blood group incompatibility haemolytic disease, is low in
side effect, and has a remarkable clinical popularization value.